Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Galanin receptor subtypes.

T A Branchek1, K E Smith, C Gerald

  • 1Synaptic Pharmaceutical Corporation, 215 College Road, Paramus, NJ 07652, USA. tabranchek@synapticcorp.com

Trends in Pharmacological Sciences
|February 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomolecular correlates of incubated sucrose-seeking within ventromedial prefrontal cortex are sex- and subregion-selective.

Pharmacology, biochemistry, and behavior·2025
Same author

An unexpectedly shrunken bandgap in V<sub>2</sub>O<sub>5</sub>nanoparticles.

Journal of physics. Condensed matter : an Institute of Physics journal·2025
Same author

Public understandings of potential policy responses to health inequalities: Evidence from a UK national survey and citizens' juries in three UK cities.

Social science & medicine (1982)·2021
Same author

Prospective <i>Salmonella</i> Enteritidis surveillance and outbreak detection using whole genome sequencing, Minnesota 2015-2017.

Epidemiology and infection·2020
Same author

Animal agriculture exposures among Minnesota residents with zoonotic enteric infections, 2012-2016.

Epidemiology and infection·2020
Same author

Evaluation of Three Different Cleaners Recommended for Ultrafiltration Systems by Direct Observations of Commercial-Scale Spiral-Wound Ultrafiltration Membranes <sup>1</sup>.

Journal of food protection·2019

Galanin is a neuropeptide with diverse effects, and three receptor subtypes (GAL1, GAL2, GAL3) have been identified. Challenges remain in linking these receptors to galanin

Area of Science:

  • Neuroscience and Pharmacology

Background:

  • Galanin, a neuropeptide, is broadly distributed in the brain and peripheral tissues.
  • It mediates a wide spectrum of physiological functions.
  • Previous pharmacological studies suggested the existence of multiple galanin receptor subtypes.

Purpose of the Study:

  • To review the current understanding of galanin receptor subtypes.
  • To highlight challenges in galanin receptor research, including the development of selective antagonists.
  • To discuss the association between cloned receptors and known physiological actions of galanin.

Main Methods:

  • Review of published pharmacological and molecular cloning studies.
  • Analysis of G-protein-coupled receptor (GPCR) cloning data for galanin receptors.
  • Discussion of challenges in receptor-ligand interaction and functional characterization.

Related Experiment Videos

Main Results:

  • Three G-protein-coupled receptor (GPCR) subtypes for galanin have been cloned since 1994: GAL1, gal2, and gal3.
  • Currently, potent and selective antagonists are not available for any of these cloned receptors.
  • A significant gap exists in linking cloned receptor subtypes to specific physiological effects of galanin.

Conclusions:

  • The cloning of three galanin receptor subtypes (GAL1, gal2, gal3) represents a significant advancement.
  • The lack of selective antagonists hinders detailed functional studies and therapeutic development.
  • Further research is crucial to elucidate the precise roles of each receptor subtype and to investigate potential additional galanin receptors.